U.S., Dec. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07271823) titled 'Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer' on Nov. 26.
Brief Summary: This project aims to establish a single-center, prospective, observational clinical cohort for pancreatic cancer immunotherapy. It plans to enroll 100 patients with advanced pancreatic cancer, collecting tumor tissue sections, plasma, serum, and fecal samples. Through multi-omics analysis including proteomics, metabolomics, and microbiomics, the project will develop predictive models for immunotherapy response.
Study Start Date: Sept. 01, 2024
Study Type: OBSERVATIONAL
Condition:
Pancreatic Cancer Non-resectable
Inter...